Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $43 to $47.
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $43 to $47.